GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » Biotage AB (OTCPK:BITGF) » Definitions » Gross Margin %

Biotage AB (Biotage AB) Gross Margin % : 63.12% (As of Mar. 2024)


View and export this data going back to 2010. Start your Free Trial

What is Biotage AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Biotage AB's Gross Profit for the three months ended in Mar. 2024 was $29.1 Mil. Biotage AB's Revenue for the three months ended in Mar. 2024 was $46.1 Mil. Therefore, Biotage AB's Gross Margin % for the quarter that ended in Mar. 2024 was 63.12%.


The historical rank and industry rank for Biotage AB's Gross Margin % or its related term are showing as below:

BITGF' s Gross Margin % Range Over the Past 10 Years
Min: 54.43   Med: 61.06   Max: 62.23
Current: 62.14


During the past 13 years, the highest Gross Margin % of Biotage AB was 62.23%. The lowest was 54.43%. And the median was 61.06%.

BITGF's Gross Margin % is ranked better than
63.57% of 796 companies
in the Medical Devices & Instruments industry
Industry Median: 53.575 vs BITGF: 62.14

Biotage AB had a gross margin of 63.12% for the quarter that ended in Mar. 2024 => Durable competitive advantage

The 5-Year average Growth Rate of Gross Margin for Biotage AB was -0.10% per year.


Biotage AB Gross Margin % Historical Data

The historical data trend for Biotage AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotage AB Gross Margin % Chart

Biotage AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 62.23 61.08 61.28 60.54 61.71

Biotage AB Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 60.94 61.86 62.81 61.12 63.12

Competitive Comparison of Biotage AB's Gross Margin %

For the Medical Instruments & Supplies subindustry, Biotage AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Biotage AB's Gross Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, Biotage AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Biotage AB's Gross Margin % falls into.



Biotage AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Biotage AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=112 / 181.524
=(Revenue - Cost of Goods Sold) / Revenue
=(181.524 - 69.509) / 181.524
=61.71 %

Biotage AB's Gross Margin for the quarter that ended in Mar. 2024 is calculated as


Gross Margin % (Q: Mar. 2024 )=Gross Profit (Q: Mar. 2024 ) / Revenue (Q: Mar. 2024 )
=29.1 / 46.104
=(Revenue - Cost of Goods Sold) / Revenue
=(46.104 - 17.001) / 46.104
=63.12 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Biotage AB  (OTCPK:BITGF) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Biotage AB had a gross margin of 63.12% for the quarter that ended in Mar. 2024 => Durable competitive advantage


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Biotage AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Biotage AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Biotage AB (Biotage AB) Business Description

Traded in Other Exchanges
Address
Vimpelgatan 5, Box 8, Uppsala, SWE, 751 03
Biotage AB provides separation technology and solutions for analytical and organic chemistry from research to commercial analytical laboratories and industrial applications. Its customers span a broad range of market segments including pharmaceutical, biotech, diagnostic, contract research, and contract manufacturers as well as clinical, forensic, and academic laboratories in addition to organizations focused on food safety, clean water, and environmental sustainability. It serves three geographic markets: The Americas, APAC (Asia-Pacific,) and EMEA (Europe, Middle East & Africa). The company's product areas include Small Molecules & Synthetic Therapeutics, Biologics & Advanced Therapeutics, Scale-Up, Diagnostics, Analytical Testing, and Water & Environmental Testing.

Biotage AB (Biotage AB) Headlines

From GuruFocus

New capacity helps eliminate bottleneck for COVID-19 vaccines

By PRNewswire PRNewswire 08-16-2021

Biotage AB (publ) Interim report January - September 2021

By PRNewswire PRNewswire 10-28-2021

Issue and re-purchase of class C shares for incentive program

By PRNewswire PRNewswire 11-30-2021

Biotage AB (publ) Interim report January - March 2021

By PRNewswire PRNewswire 04-28-2021

Change in number of shares and votes

By PRNewswire PRNewswire 12-30-2021

Biotage appoints Nomination Committee

By PRNewswire PRNewswire 10-25-2021

Biotage moves to the large cap segment

By PRNewswire PRNewswire 01-03-2022

Biotage AB (publ) Year-end report January - December 2021

By PRNewswire PRNewswire 02-11-2022